Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Short term Debt (2016 - 2025)

Historic Short term Debt for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Q3 2025 value amounting to $199.5 million.

  • Ironwood Pharmaceuticals' Short term Debt changed N/A to $199.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.5 million, marking a year-over-year change of. This contributed to the annual value of $199.6 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Short term Debt is $199.5 million.
  • In the past 5 years, Ironwood Pharmaceuticals' Short term Debt registered a high of $199.8 million during Q1 2024, and its lowest value of $112.9 million during Q2 2021.
  • For the 5-year period, Ironwood Pharmaceuticals' Short term Debt averaged around $166.2 million, with its median value being $199.2 million (2023).